Prednisone Active Not Recruiting Phase 2 Trials for Multiple Myeloma (MM) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01054144Study of Single Agent Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma
NCT02294357Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib
NCT01160107Revlimid And Prednisone Followed By Revlimid, Melphalan And Prednisone In Multiple Myeloma Patients
NCT02302495Study of Carfilzomib Weekly Plus Melphalan and Prednisone in Untreated Symptomatic Elderly Multiple Myeloma
NCT01190787Subcutaneous Velcade Plus Oral Melphalan and Prednisone or Plus Cycloposphamide and Prednisone or Plus Prednisone
NCT02237261Bendamustine, Prednisone and VelcadeĀ® for First-line Treatment of Patients With Symptomatic Multiple Myeloma